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Introduction. Arterial hypertension within diabetes is an interdisciplinary subject of interest for 
cardiology and endocrinology. This topic is of major importance, taking into account the number 
of diabetic patients in association with hypertension is progressively increasing, and this worsens 
the microvascular and macrovascular complications outcomes, and increases the mortality rates. 
Aim of the study. Study of the frequency of high blood pressure of people with type 2 diabetes, 
the risk factors for developing it, and the impact of hypertension on diabetes complications. 
Materials and methods. The study sample included 120 patients with type 2 diabetes treated in 
the Endocrinology section of the Republican Clinical Hospital during 2017. We assesed tension 
values, body mass index, and the stress level in all patients using a questionnaire. The 
examination quotient was divided into groups depending on the presence or absence of 
hypertension (HT). 
Results. Out of the total number of patients 47.5 % were women aged between 39-70, the 
average age being 56.05 years, and 52.5 % men aged between 39-73 with average age of 54.76 
years. The average values for SBP were 146.75 mmHg, and 89mmHg for DBP. Hypertension 
was determined in 75% of patients, 25% being normotensive. The anamnestic data revealed that 
in 45% of the HT patients, the diagnosis of HT preceded that of diabetes; in 23% HT was 
diagnosed concomitantly with diabetes and in 32% HT occurred during the course of diabetes. 
According to the HT classification we determined that 57% had first degree HT; 30% - second 
degree HT, and 23% - third grade HT. In the non-HT group 73% patients were non-obese 
(normoponderal and overweight), 27% were obese, while in the HT group 42% were non-obese 
patients, and 58% - obese. There is a statistically significant correlation between BMI and HT (p 
<0.05). By analysing the data, we noted that neuropathy was present in 100% patients with HT 
and 93.33% normotensives; retinopathy - in 30% of the HT group, and 20% in the normotensive 
group; cardiopathy in 33.33% with HT, and in 23.33% normotensives; nephropathy in 6.42% 
with HT, and in 4.44% normotensives. The questionnaire compared the level of stress between 
normotensitives and HT, and determined that 34% nonHT patients had a medium stress level, 
23% high stress levels, and 8% an exaggerated stress level. Out of the HT patients 66% had a 
medium stress level, 77% a high stress level, and 82% an exaggerated stress level. 
Conclusions. Our results confirmed the results of existing research data regarding the high 
incidence of hypertension in patients with type 2 diabetes. Obesity has a major negative impact 
on the onset and evolution of hypertension. Most complications have been observed in HT 
patients, and therefore we can not state what was the negative impact of hypertension on diabetes 
complications. Prevention of stress situations has a beneficial effect on blood pressure. 
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Introduction. The pathogenesis of diabetes type II and obesity is based on a mix of genetic 
factors, disorders of the immune balance and lifestyle factors. Сombination of this pathological 
processes increases the risk of vascular complications and becomes a significant social and 
economic problem of mankind. This negative trend requires a detailed examination of all 
possible causes of chronic inflammation, which is one of the key factors in kidney failure 
progression.  
Aim of the study. To evaluate the indicators: interleukin-1(IL-1), interleukin-6(IL-6), and 
transforming growth factor-β1(TGF β1) in patients with diabetic nephropathy(DN) and obesity.  
Materials and methods. For the study 43 patients with diabetes type II were selected, aged 
between 41 - 63 years, with at least 10 years duration of the disease. Glomerular filtration rate 
(GFR) in all patients was not less than 90 ml/min. All patients were divided into two groups: 
group 1 included patients with DN stage III without concomitant obesity (22 people), the 2nd 
group included patients with DN stage III and I degree obesity (21 people). The control group 
consisted of 22 healthy subjects. Exclusion criteria: courses of antibiotic therapy of any duration 
for the last 4 weeks, cancer. In addition to general clinical methods of examination, all patients 
underwent determination of IL-1, IL-6 and TGF β1 levels. 
Results. Analysis of clinical and laboratory parameters examined patients showed increasing 
levels of IL-1, IL-6 and TGF β1 compared with those parameters of healthy subjects(p <0,05). 
Levels of proinflammatory cytokines were higher in patients with concomitant obesity.  
Conclusions. The analysis of clinical and laboratory parameters revealed the presence of an 
imbalance in immunogram in obese and non-obese patients with chronic kidney disease. 
However, the changes in patients with II degree obesity were more significant. In this same 
group the patients showed a more pronounced impairment of renal function, indicating a more 
severe course of disease in obese patients. It means that this variant of the disease is more 
unfavorable. 
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Introduction. Renal cell carcinoma(RCC) represents approximately 2-3% of all malignancies 
with variations in regional incidence. Over the last two decades the incidence of RCC increased 
by about 2%, both worldwide and in Republic of Moldova. Obesity is one of the well-established 
risk factors for RCC. Obesity has also been increasing throughout the world. The increasing 
prevalence of obesity might therefore, at least partially, explain the increasing incidence of renal 
cell cancer. 
Aim of the study. This study was undertaken in order to assess whether obesity carries higher 
risk for renal cell cancer. 
Materials and methods. This study included 734 patients, 438 (59.7%) males and 296 (40.3%) 
females, with histopathologically confirmed renal cell carcinoma, who were treated between 
2013 and 2015 in the Department of Urology of the Oncology Institute of the Republic of 
Moldova. Diagnosis of obesity was confirmed by the World Health Organization standard 
recommended method by using body mass index (BMI) scale. Variables examined also included 
age and sex. BMI was investigated by using established categories for normal weight (<25 
kg/m2), overweight (25-30 kg/m2), and obese (≥30 kg/m2). 
